Bioquell has reported a strong set of interim results, with reported revenues +9% to £15.7m. Excluding Defence sales and the disposed-of Airflow business, like-for-like revenues increased by 15% on a constant currency basis. In light of the strong H1 showing and positive commentary over the outlook, we upgrade our EPS forecasts by 10% this year and 13% in FY19, the fourth double digit upgrades we have made in the last 12m. The growth opportunity is by no means exhausted however and we see the FY ....
